Biotech and Pharmaceuticals
Bristol Myers Squibb earnings top estimates even as top-selling drug fights generic competition
Bristol Myers Squibb on Thursday reported quarterly adjusted earnings that topped expectations and posted revenue in line with estimates, even as sales of the company’s popular blood cancer drug Revlimid plummeted due to generic competition. Bristol Myers, one of the world’s largest pharmaceutical companies, raked in $10.96 billion in revenue for the third quarter, down […]
Read More
Merck results beat expectations on strong Keytruda sales, surprise Covid drug growth
Merck headquarters in Rahway, New Jersey, on Tuesday, April 18, 2023. Christopher Occhicone | Bloomberg | Getty Images Merck on Thursday reported third-quarter revenue and adjusted earnings that topped expectations on strong sales of its blockbuster cancer drug Keytruda, HPV vaccine Gardasil and surprisingly, its Covid drug Lagevrio. The pharmaceutical giant also increased its full-year […]
Read More
More convenient form of breakthrough Alzheimer’s drug Leqembi shows promising results in study
Eisai on Wednesday said an injectable version of the Alzheimer’s drug Leqembi showed promising initial results in a clinical trial, potentially paving the way for a new and more convenient option for administering the antibody treatment. However, the injection did not cause lower rates of brain swelling and bleeding, which are Leqembi’s most concerning side […]
Read More
Mike Johnson elected Residence speaker, placing Louisiana Republican in the highlight
Republican Rep. Mike Johnson of Louisiana was elected speaker of the Dwelling of Associates on Wednesday, ending a 3-week management crisis that has paralyzed Congress. Vice chairman of the Home Republican meeting and a tough-proper conservative, Johnson had maintained a lower community profile right until he was thrust into the spotlight this week immediately after […]
Read More
RSV vaccine from GSK shows potential to protect adults 50 to 59
A vaccine from GlaxoSmithKline showed the potential to protect adults ages 50 to 59 from respiratory syncytial virus in a late-stage clinical trial, the company said Wednesday. The initial trial results suggest that GSK’s shot, known as Arexvy, could help protect a wider population from RSV, a disease that causes thousands of hospitalizations and deaths […]
Read More
Swiss pharma huge Roche agrees $7.1 billion offer to get Telavant Holdings
A image exhibiting the symbol of Swiss pharmaceutical huge Roche in Basel. SEBASTIEN BOZON | AFP | Getty Illustrations or photos Swiss health and fitness care corporation Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction. Telavant creates drugs for men and women suffering from inflammatory and fibrotic ailments and […]
Read More
These stocks are trying to solve a major shortcoming of weight loss drugs: Shrinking muscle mass
One of the downsides of taking new anti-obesity medications is that patients tend to lose lean muscle mass along with body fat. What this means for patients over the long term isn’t fully known, but there are several pharmaceutical companies studying the side effect and hoping to develop therapies that might regulate the condition. In […]
Read More
CVS to pull certain cold medicines containing decongestant phenylephrine from store shelves
Cold and flu medicine including NyQuil sit on a store shelf in Miami on Sept. 12, 2023. Joe Raedle | Getty Images CVS is removing some of the most common cough and cold medicines from its store shelves and will no longer sell them, a company spokesperson told CNBC on Thursday. The company’s decision comes […]
Read More
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Sanofi Lantus brand insulin pens are arranged for a photograph in the Brooklyn borough of New York, U.S., on Friday, April 5, 2019. Alex Flynn | Bloomberg | Getty Images Americans, regardless of their insurance status, can now access Sanofi‘s most widely prescribed insulin for $35 through the prescription drug savings company GoodRx, the companies […]
Read More
Pfizer to price Covid drug Paxlovid at $1,390 per course
Paxlovid, Pfizer’s antiviral medication to treat the coronavirus disease, is displayed in this picture taken on Oct. 7, 2022. Wolfgang Rattay | Reuters Pfizer will price a five-day course of its Covid antiviral drug Paxlovid at $1,390 when the company starts to transition it to the commercial market later this year. A company spokesperson on […]
Read More